NCT02238678

Brief Summary

It has been demonstrated that ligaments, both cardinal and uterosacral contain a considerable amount of autonomic nerve tissues. The resection of deep infiltrating endometriotic nodules at the level of the uterosacral ligaments or the rectovaginal space is supposed to damage the supplying autonomic nerve fibers of the lower urinary tract. The bladder receives motor and sensitive innervations from both the sympathetic fibers, most of which arise from the hypogastric plexuses and nerves, and the parasympathetic fibers, which arise from the pelvic splanchnic nerves and the inferior hypogastric plexus; therefore, even bladder function may be impaired in women affected by deep endometriosis. Very few data have been published regarding the urodynamic functional evaluation of bladder in patient with deep endometriosis.So far, it is unknown if the surgery itself causes the postoperative bladder dysfunction or if the surgery unmasks a subclinically pre-existing detrusor pathology. Since the urinary postoperative complications have a strong impact on quality of life of the deep endometriosis patients and often requires management (due to a poor spontaneous remission), it is crucial a better understanding of the problem. That will help for a more appropriate pre-operative counselling. Aims of this study are to evaluate the bladder function before and after deep endometriosis surgery, using standardized validated instruments and to correlate the localisation of the endometriosis lesion, the type/area of surgical dissection with the postoperative bladder function. This is a prospective multicenter cohort study involving the Department of General Gynaecology and Gynecological Oncology of Medical University of Vienna (Austria) and the Department of Obstetrics and Gynaecology of Insubria University, Varese (Italy). A total of 50 patients are planned to be included. The study protocol consider a Preoperative Assessment (clinical examination, transvaginal pelvic ultrasound, preoperative specific questionnaire including obstetric, medical, and surgical history and standardized questions on pelvic floor dysfunctions, standardized instrumental assessment of the pelvic floor) a Intraoperative Assessment (during laparoscopy, the localizations of endometriotic lesions recorded and identified by anatomical sites, numbers, and depth of infiltration). Before and 3 months after surgery a Urodynamic assessment is planned.

Trial Health

50
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2014

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2014

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

August 28, 2014

Completed
15 days until next milestone

First Posted

Study publicly available on registry

September 12, 2014

Completed
Last Updated

September 12, 2014

Status Verified

August 1, 2014

Enrollment Period

Same day

First QC Date

August 28, 2014

Last Update Submit

September 10, 2014

Conditions

Outcome Measures

Primary Outcomes (1)

  • Urodynamic assessment after deep infiltrating endometriosis surgery

    to evaluate the bladder function before and after deep endometriosis surgery (Unit of Measure: First Desire (ml) from Urodynamic Assessment)

    2 years

Secondary Outcomes (2)

  • Bladder symptoms after surgery for deep infiltrating endometriosis

    2 years

  • correlation between localisation of the endometriosis lesion and postoperative bladder function.

    2 years

Study Arms (1)

Deep endometriosis patients

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

\- Patients with confirmed diagnosis of deep infiltrating endometriosis requiring surgical treatment

You may qualify if:

  • Patients with confirmed diagnosis of deep infiltrating endometriosis requiring surgical treatment
  • Patient planned to be submitted to laparoscopic surgery finalize to eradicate the endometriosis pathology
  • Naïve patients for OAB treatment.
  • Patients must be capable of independent toileting
  • Patients must be able to fully understand all study procedures and to provide written informed consent to study participation

You may not qualify if:

  • Patient previously submitted to pelvic surgery for any urogynaecological disease;
  • Patients previously submitted to DE surgery
  • Patient with documented clinical, instrumental, or laparoscopic preoperative diagnosis of bladder endometriosis;
  • Patient with documented urinary tract infection
  • Patient with history of diabetes mellitus, psychiatric, or neurological disease;
  • Pregnant patients
  • Patients \< 18 years

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Laterza RM, Uccella S, Serati M, Umek W, Wenzl R, Graf A, Ghezzi F. Is the Deep Endometriosis or the Surgery the Cause of Postoperative Bladder Dysfunction? J Minim Invasive Gynecol. 2022 Apr;29(4):567-575. doi: 10.1016/j.jmig.2021.12.017. Epub 2022 Jan 2.

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr. med

Study Record Dates

First Submitted

August 28, 2014

First Posted

September 12, 2014

Study Start

June 1, 2014

Primary Completion

June 1, 2014

Last Updated

September 12, 2014

Record last verified: 2014-08